(Q84108503)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22576730%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

title

Stay vigilant: a glitazone (pioglitazone) can hide a glitazar! (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22576730%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

author name string

Dominique Hillaire-Buys

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22576730%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

Jean-Luc Faillie

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22576730%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

Jean-Louis Montastruc

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22576730%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

Pierre Petit

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22576730%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

publication date

11 May 2012

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22576730%20AND%20SRC:MED&resulttype=core&format=json

European Journal of Clinical Pharmacology

1 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22576730%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

volume

68

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22576730%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

issue

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22576730%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

page(s)

1681-1683

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22576730%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/s00228-012-1299-1

1 February 2020

exact match

0 references

cites work

PPARalpha and PPARgamma are co-expressed, functional and show positive interactions in the rat urinary bladder urothelium

1 reference

12 December 2020

Pioglitazone and bladder cancer

1 reference

12 December 2020

Lack of pharmacokinetic interaction between dapagliflozin, a novel sodium-glucose transporter 2 inhibitor, and metformin, pioglitazone, glimepiride or sitagliptin in healthy subjects

1 reference

12 December 2020

Neoplastic and non-neoplastic changes in F-344 rats treated with Naveglitazar, a gamma-dominant PPAR alpha/gamma agonist

1 reference

12 December 2020

Rat Urinary Bladder Carcinogenesis by Dual-Acting PPARalpha + gamma Agonists

1 reference

12 December 2020

Suppressive effects of acid-forming diet against the tumorigenic potential of pioglitazone hydrochloride in the urinary bladder of male rats

1 reference

12 December 2020

Safety issues and prospects for future generations of PPAR modulators

1 reference

12 December 2020

Pharmacology of PPARalpha, PPARgamma and dual PPARalpha/gamma agonists in clinical development

1 reference

12 December 2020

Rosiglitazone, a PPAR gamma agonist: potent promoter of hydroxybutyl(butyl)nitrosamine-induced urinary bladder cancers

1 reference

12 December 2020

Pioglitazone and risk of bladder cancer among diabetic patients in France: a population-based cohort study

1 reference

12 December 2020

Urothelial carcinogenesis in the urinary bladder of rats treated with naveglitazar, a gamma-dominant PPAR alpha/gamma agonist: lack of evidence for urolithiasis as an inciting event

1 reference

12 December 2020